Univest
Univest
  • Markets
  • 3 Branded Drug Maker, Fluorine Chemicals Maker and Transformers Maker Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Navin Fluorine International and CG Power and Industrial Solutions

    • November 5, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Branded Drug Maker, Fluorine Chemicals Maker and Transformers Maker Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Navin Fluorine International and CG Power and Industrial Solutions

    Branded Drug, Fluorine and Electrical Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Navin Fluorine International and CG Power and Industrial Solutions. Compare price, valuation, return on equity and revenue growth as of 4 November 2026.

    read more
  • 3 Branded Generics Maker, Pumps and Valves Maker and Chromium and Barium Chemicals Maker Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Kirloskar Brothers and Vishnu Chemicals

    • November 4, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Branded Generics Maker, Pumps and Valves Maker and Chromium and Barium Chemicals Maker Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Kirloskar Brothers and Vishnu Chemicals

    Branded Drug, Pump and Chromium Chemical Stocks with a strong future roadmap: Lincoln Pharmaceuticals, Kirloskar Brothers and Vishnu Chemicals. Compare price, valuation, return on equity and revenue growth as of 3 November 2026.

    read more
  • 3 Branded Generics Company, Contract Development Specialist and Respiratory Medicines Leader Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Anthem Biosciences and Cipla

    • October 29, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Branded Generics Company, Contract Development Specialist and Respiratory Medicines Leader Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Anthem Biosciences and Cipla

    Generics, Contract Development and Respiratory with a strong future roadmap: Lincoln Pharmaceuticals, Anthem Biosciences and Cipla. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.

    read more